Transcenta Holding (6628) Fundamentals 2026 — Revenue Analysis | SniperIQ

.13 on the HKSE. This SniperIQ fundamentals page covers Transcenta Holding's valuation, profitability (net margin -2740.1%), revenue (¥7M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is Transcenta Holding's market cap?

Transcenta Holding (6628) has a market capitalization of approximately HK$482M, trading at HK

.13 on the HKSE. Market cap moves with the live share price.

What is Transcenta Holding's P/E ratio?

Transcenta Holding's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Transcenta Holding?

Transcenta Holding runs a net profit margin of -2740.1%, a gross margin of 23.1%, and an operating margin of -2699.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Transcenta Holding generate?

Transcenta Holding reported revenue of ¥7M for fiscal year 2025, with net income of -¥198M and earnings per share (EPS) of -0.48. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Transcenta Holding pay a dividend?

Transcenta Holding does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Transcenta Holding financially healthy?

Transcenta Holding carries a debt-to-equity ratio of 0.20x and a current ratio of 0.25x, with a market beta of -0.46. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Transcenta Holding a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Transcenta Holding (6628) the key facts are: market cap HK$482M, revenue ¥7M, 52-week range 0.98-5.8. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.